Family · Pharmaceutical analytical standards
Glipizide
A sulfonylurea for type 2 diabetes, developed in Milan in the late 1960s and in use since 1971 (in the United States since 1984): it stimulates the beta cells of the pancreas to release insulin. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Its half-life is only 2 to 5 hours, yet its effect on blood sugar can last up to a whole day.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
